{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE, Angiotensin I Converting Enzyme", "Angiotensin converting enzyme", "BAPNA, a-N-benzoyl-dl-arginine-Pnitroanilide HCl", "BP, blood pressure", "BSA, bovine serum albumin", "BSC, benzene sulphonyl chloride", "CH2Cl2, dichloromethane", "DMSO, dimethyl sulphoxide", "Enzyme kinetics", "EtOAc, Ethyl acetate", "EtOH, ethanol", "GAEs, gallic acid equivalents", "HA, hippuric acid", "HCl, Hydrochloric acid", "HHL, hippury-l-histidyl-l-leucine", "IC50, half maximal inhibitory concentration", "Km, Michaelis-Menten constant", "Lineweaver-burk plots", "M, Molar", "MeOH, methanol", "Mm, Milli mole", "Mode of inhibition", "Mu, Milli units", "QEs, quercetin equivalents", "RAS, renin-angiotensin system", "TCA, Trichloroacetic acid", "TFA, trifluoroacetic acid", "UV, ultra violet", "Vmax, Maximum velocity", "Zn2+, Zinc ion", "ZnCl2, Zinc chloride", "mL, milli litre", "mg, milligram", "n-BuOH, n-butanol", "ng, nano gram"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30671369", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "04", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jtcme.2018.02.001"], "Journal": {"ISSN": "2225-4110", "JournalIssue": {"Volume": "9", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jan"}}, "Title": "Journal of traditional and complementary medicine", "ISOAbbreviation": "J Tradit Complement Med"}, "ArticleTitle": "Mechanism & inhibition kinetics of bioassay-guided fractions of Indian medicinal plants and foods as ACE inhibitors.", "Pagination": {"StartPage": "73", "EndPage": "84", "MedlinePgn": "73-84"}, "Abstract": {"AbstractText": ["Hypertension is a becoming a major threat to the world. Angiotensin converting enzyme (ACE) is a key part in the renin angiotensin aldosterone system (RAAS) which control blood pressure. Over expression of RAAS is related with vascular hypertension, ACE inhibition has turned into a noteworthy target for controlling hypertension. In the search of lead molecules from plant origin as a substitute for toxic synthetic drugs, 25 Indian medicinal plants and foods were screened for their ACE inhibitory activity. IC<sub>50</sub> (50% inhibition of ACE) values of hydroalcoholic crude extracts and fraction were determined by a colorimetric method. Active fractions were further screened to determine the enzyme kinetics, mode, specificity and mechanism of inhibition. Standardization was done by determining total phenolics and flavonoids as gallic acid and quercetin equivalents/mg of extract respectively. Among 25 crude extracts, <i>Cynara scolymus</i> extract showed the best activity, IC<sub>50</sub> value 356.62\u202f\u03bcg/mL. ACE inhibition resulting from protein precipitation was highest in <i>Coscinium fenestratum</i>. Lineweaver-Burk plots revealed a competitive mode of inhibition for <i>Punica granatum</i> ethyl acetate fraction. Fractions of <i>Cassia occidentalis</i>, <i>Cynara scolymus</i> and <i>Embelia ribes</i> were found to be non-specific inhibitors of ACE. <i>Embelia ribes, Cassia occidentalis</i> and <i>Coscinium fenestratum</i> fractions inhibited the ACE by Zn<sup>2+</sup> ion chelation. Research revealed the potential of tested plants fractions as ACE inhibitors along with their inhibition kinetics and mechanism of inhibition. These active plant fractions might find importance in the development of potential antihypertensive agents after further investigations using preclinical and clinical trials."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytopharmaceuticals and Natural Products, Institute of Pharmacy, Nirma University of Science and Technology, S.G. Highway, Ahmadabad, 382 481, India."}], "LastName": "Khan", "ForeName": "Mohammad Yaseen", "Initials": "MY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytopharmaceuticals and Natural Products, Institute of Pharmacy, Nirma University of Science and Technology, S.G. Highway, Ahmadabad, 382 481, India."}], "LastName": "Kumar", "ForeName": "Vimal", "Initials": "V"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "J Tradit Complement Med", "NlmUniqueID": "101605474", "ISSNLinking": "2225-4110"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Vasan R.S., Larson M.G., Leip E.P. Impact of high-normal blood pressure on the risk of cardiovascular disease. N\u00a0Engl J Med. 2001;345:1291\u20131297.", "ArticleIdList": ["11794147"]}, {"Citation": "Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005:365217\u2013365223.", "ArticleIdList": ["15652604"]}, {"Citation": "Weir M.R., Dzau V.J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens. 1999;12(S9) 205S\u201313S.", "ArticleIdList": ["10619573"]}, {"Citation": "Carson P.E. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure. Am Heart J. 2000;140:361\u2013366.", "ArticleIdList": ["10966531"]}, {"Citation": "Shlipak M.G., Browner W.S., Noguchi H., Massie B., Frances C.D., McClellan M. Comparison of the effects of angiotensin converting\u2013enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med. 2001;110:425\u2013433.", "ArticleIdList": ["11331052"]}, {"Citation": "Hebert L.A., Falkenhain M.E., Nahman N.S., Jr., Cosio F.G., O'Dorisio T.M. Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol. 1999;19:1\u20136.", "ArticleIdList": ["10085442"]}, {"Citation": "Hemels M.E., Bennett H.A., Bonari L., Han D., Traverso M.L., Einarson T.R. HOPE study impact on ACE inhibitors use. Ann Pharmacother. 2003;37:640\u2013645.", "ArticleIdList": ["12708937"]}, {"Citation": "Alderman C.P. Adverse effects of the angiotensin-converting enzyme inhibitors. Ann Pharmacother. 1996;30:55\u201361.", "ArticleIdList": ["8773167"]}, {"Citation": "Wood R.I. Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. Br J Clin Pharmacol. 1995;39:265\u2013270.", "ArticleIdList": ["PMC1365002", "7619667"]}, {"Citation": "Dubey N.K., Kumar R., Tripathi P. Global promotion of herbal medicine: India's opportunity. Curr Sci. 2004;86:37\u201341."}, {"Citation": "Somanadhan B., Varughese G., Palpu P. An ethnopharmacological survey for potential angiotensin converting enzyme inhibitors from Indian medicinal plants. J\u00a0Ethnopharmacol. 1999;65:103\u2013112.", "ArticleIdList": ["10465650"]}, {"Citation": "Wagner H., Elbl G., Lotter H., Guinea M. Evaluation of natural products as inhibitors of angiotension I \u2014 converting enzyme (ACE) Pharmacol Lett. 1991;1:15\u201318."}, {"Citation": "Machado T.B., Pinto A.V., Pinto M.C. In\u00a0vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2003;21:279\u2013284.", "ArticleIdList": ["12636992"]}, {"Citation": "Dewanto V., Wu X., Liu R.H. Processed sweet corn has higher antioxidant activity. J\u00a0Agric Food Chem. 2002;50:4959\u20134964.", "ArticleIdList": ["12166989"]}, {"Citation": "Chang C.C., Yang M.H., Wen H.M., Chern J.C. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J\u00a0Food Drug Anal. 2002;10:178\u2013182."}, {"Citation": "Cushman D.W., Cheung H.S. Spectrophotometric assay and properties of the angiotensin I-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637\u20131648.", "ArticleIdList": ["4355305"]}, {"Citation": "Huggins C.G., Thampi N.S. A\u00a0simple method for the determination of angiotensin I converting enzyme. Life Sci. 1968;7:633\u2013639.", "ArticleIdList": ["4299704"]}, {"Citation": "Carmel A., Yaron A. An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase. Eur J Biochem. 1978;87:265\u2013273.", "ArticleIdList": ["208842"]}, {"Citation": "Holmquist B., B\u00fcnning P., Riordan J.F. A\u00a0continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem. 1979;95:540\u2013548.", "ArticleIdList": ["222167"]}, {"Citation": "Wu J., Aluko R.E., Muir A.D. Improved method for direct high-performance liquid chromatography assay of angiotensin-converting enzyme-catalyzed reactions. J\u00a0Chromatogr A. 2002;950:125\u2013130.", "ArticleIdList": ["11990985"]}, {"Citation": "Jimsheena V.K., Gowda L.R. Colorimetric, high-throughput assay for screening angiotensin I-converting enzyme inhibitors. Anal Chem. 2009;81:9388\u20139394.", "ArticleIdList": ["19839596"]}, {"Citation": "Chen J., Liu S., Ye R., Cai G., Ji B., Wu Y. Angiotensin-I converting enzyme (ACE) inhibitory tripeptides from rice protein hydrolysate: purification and characterization. Journal of Functional Foods. 2013;5:1684\u20131692."}, {"Citation": "Priyanto A.D., Doerksen R.J., Chang C.I. Screening, discovery, and characterization of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins. Journal of proteomics. 2015;128:424\u2013435.", "ArticleIdList": ["26344130"]}, {"Citation": "Liu J.C., Hsu F.L., Tsai J.C. Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme. Life Sci. 2003;73:1543\u20131555.", "ArticleIdList": ["12865094"]}, {"Citation": "Stanton A. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders. Am J Cardiovasc Drugs. 2003;3:389\u2013394.", "ArticleIdList": ["14728059"]}, {"Citation": "Unger T., Gohlke P. Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovasc Res. 1994;28:146\u2013158.", "ArticleIdList": ["8143294"]}, {"Citation": "Elbl G., Wagner H. A\u00a0new method for the in\u00a0vitro screening of inhibitors of angiotensin-converting enzyme (ACE), using the chromophore-and fluorophore-labelled substrate, dansyltriglycine. Planta Med. 1991;57:137\u2013141.", "ArticleIdList": ["1891496"]}, {"Citation": "Dorer F.E., Kahn J.R., Lentz K.E., Levine M., Skeggs L.T. Hydrolysis of bradykinin by angiotensin-converting enzyme. Circ Res. 1974;34:824\u2013827.", "ArticleIdList": ["4364999"]}, {"Citation": "Jaspard E., Wei L., Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J\u00a0Biol Chem. 1993;268:9496\u20139503.", "ArticleIdList": ["7683654"]}, {"Citation": "Campbell D.J. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE. Clin Exp Pharmacol Physiol. 1995;22:903\u2013911.", "ArticleIdList": ["8846511"]}, {"Citation": "Segel I.H. Wiley; New York: 1975. Enzyme Kinetics."}, {"Citation": "Matthews B.W., Weaver L.H., Kester W.R. The conformation of thermolysin. J\u00a0Biol Chem. 1974;249:8030\u20138044.", "ArticleIdList": ["4214815"]}, {"Citation": "Webb J.L. Academic Press; New York, NY, USA: 1963. Enzyme and Metabolic Inhibitors; pp. 149\u2013188."}, {"Citation": "Bachmetov L., Gal Tanamy M., Shapira A. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J\u00a0Viral Hepat. 2012;19:e81\u2013e88.", "ArticleIdList": ["22239530"]}, {"Citation": "Yadav J.P., Arya V., Yadav S., Panghal M., Kumar S., Dhankhar S. Cassia occidentalis L.: a review on its ethnobotany, phytochemical and pharmacological profile. Fitoterapia. 2010;81:223\u2013230.", "ArticleIdList": ["19796670"]}, {"Citation": "Rai R.V., Rajesh P.S., Kim H.M. Medicinal use of Coscinium fenestratum (Gaertn.) Colebr.: an short review. Oriental Pharmacy and Experimental Medicine. 2013;13:1\u20139."}, {"Citation": "Chen C.H., Lin J.Y., Lin C.N., Hsu S.Y. Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum. J\u00a0Nat Prod. 1992;55:691\u2013695.", "ArticleIdList": ["1517742"]}, {"Citation": "Lacaille-Dubois M.A., Franck U., Wagner H. Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine. 2001;8:47\u201352.", "ArticleIdList": ["11292239"]}, {"Citation": "Balasuriya B.N., Rupasinghe H.V. Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Functional Foods in Health and Disease. 2011;1:172\u2013188."}, {"Citation": "Guerrero L., Castillo J., Qui\u00f1ones M. Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLoS One. 2012;7 e49493.", "ArticleIdList": ["PMC3504033", "23185345"]}, {"Citation": "Actis-Goretta L., Ottaviani J.I., Fraga C.G. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J\u00a0Agric Food Chem. 2006;54:229\u2013234.", "ArticleIdList": ["16390204"]}, {"Citation": "Al Shukor N., Van Camp J., Gonzales G.B. Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: a study of structure activity relationships. J\u00a0Agric Food Chem. 2013;61:11832\u201311839.", "ArticleIdList": ["24219111"]}, {"Citation": "Thippeswamy B.S., Mahendran S., Biradar M.I. Protective effect of embelin against acetic acid induced ulcerative colitis in rats. Eur J Pharmacol. 2011;654:100\u2013105.", "ArticleIdList": ["21185828"]}, {"Citation": "Liu P., Kallio H., L\u00fc D., Zhou C., Yang B. Quantitative analysis of phenolic compounds in Chinese hawthorn (Crataegus spp.) fruits by high performance liquid chromatography\u2013electrospray ionisation mass spectrometry. Food Chem. 2011;127:1370\u20131377.", "ArticleIdList": ["25214140"]}, {"Citation": "Brain K.R. Accumulation of L-DOPA in cultures from Mucuna pruriens. Plant Sci Lett. 1976;7:157\u2013161."}, {"Citation": "Machado T.D., Leal I.C., Amaral A.C., Santos K., Silva M.G., Kuster R.M. Antimicrobial ellagitannin of Punica granatum fruits. J\u00a0Braz Chem Soc. 2002;13:606\u2013610."}, {"Citation": "Ercisli S., Orhan E. Chemical composition of white (Morus alba), red (Morus rubra) and black (Morus nigra) mulberry fruits. Food Chem. 2007;103:1380\u20131384."}, {"Citation": "Ali I., Khan F.G., Suri K.A. In\u00a0vitro antifungal activity of hydroxychavicol isolated from Piper betle L. Ann Clin Microbiol Antimicrob. 2010;9:7.", "ArticleIdList": ["PMC2841090", "20128889"]}, {"Citation": "Zhu X., Zhang H., Lo R. Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J\u00a0Agric Food Chem. 2004;52:7272\u20137278.", "ArticleIdList": ["15563206"]}, {"Citation": "Kim I.S., Yang M., Lee O.H., Kang S.N. The antioxidant activity and the bioactive compound content of Stevia rebaudiana water extracts. LWT-Food Science and Technology. 2011;44:1328\u20131332."}]}], "History": [{"Year": "2017", "Month": "2", "Day": "27"}, {"Year": "2018", "Month": "1", "Day": "28"}, {"Year": "2018", "Month": "2", "Day": "18"}, {"Year": "2019", "Month": "1", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "4", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["30671369", "PMC6335474", "10.1016/j.jtcme.2018.02.001", "S2225-4110(18)30013-0"]}}]}